OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhalable neutralizing antibodies – promising approach to combating respiratory viral infections
Michael Y.T. Chow, Harry W. Pan, Han Cong Seow, et al.
Trends in Pharmacological Sciences (2022) Vol. 44, Iss. 2, pp. 85-97
Open Access | Times Cited: 14

Showing 14 citing articles:

Fc-binding nanodisc restores antiviral efficacy of antibodies with reduced neutralizing effects against evolving SARS-CoV-2 variants
Jaehyeon Hwang, Soyun Choi, Beom Kyu Kim, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access

Neutralisation of SARS-CoV-2 by monoclonal antibody through dual targeting powder formulation
Han Cong Seow, Jian‐Piao Cai, Harry W. Pan, et al.
Journal of Controlled Release (2023) Vol. 358, pp. 128-141
Open Access | Times Cited: 11

Safety and efficacy of inhaled IBIO123 for mild-to-moderate COVID-19: a randomised, double-blind, dose-ascending, placebo-controlled, phase 1/2 trial
Bruno Maranda, Sébastien M. Labbé, Magali Lurquin, et al.
The Lancet Infectious Diseases (2023)
Closed Access | Times Cited: 7

Exploring shark VNAR antibody against infectious diseases using phage display technology
Hui Ting Lim, Boon Hui Kok, Chiuan Yee Leow, et al.
Fish & Shellfish Immunology (2023) Vol. 140, pp. 108986-108986
Closed Access | Times Cited: 2

Strategies for overcoming the biological barriers associated with the administration of inhaled monoclonal antibodies for lung diseases
Maria Gabriella Matera, Luigino Calzetta, Barbara Rinaldi, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 8, pp. 1085-1095
Closed Access | Times Cited: 2

Progress in novel delivery technologies to improve efficacy of therapeutic antibodies
Wenli Sun, Yanling Wu, Tianlei Ying
Antiviral Research (2024) Vol. 225, pp. 105867-105867
Open Access

Dry powder formulations of hyperimmune serum
Annalisa Bianchera, Gaetano Donofrío, Fabio Sonvico, et al.
Drug Delivery and Translational Research (2024)
Open Access

In vivo antiviral efficacy of LCTG-002, a pooled, purified human milk secretory IgA product, against SARS-CoV-2 in a murine model of COVID-19
Viraj Mane, Rikin Mehta, Nadine Álvarez, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access

Novel strategies in systemic and local administration of therapeutic monoclonal antibodies
Monika Prašnikar, Maja Bjelošević Žiberna, Mirjam Gosenca Matjaž, et al.
International Journal of Pharmaceutics (2024) Vol. 667, pp. 124877-124877
Open Access

A breath of fresh air: inhaled antibodies to combat respiratory infectious diseases - a clinical trial overview
Noémie Alphonse, Thomas Sécher, Nathalie Heuzé-Vourc’h
Expert Opinion on Drug Delivery (2024)
Closed Access

Enhanced powder dispersion of dual-excipient spray-dried powder formulations of a monoclonal antibody and its fragment for local treatment of severe asthma
Harry W. Pan, Jinlin Guo, Lingqiao Zhu, et al.
International Journal of Pharmaceutics (2023) Vol. 644, pp. 123272-123272
Open Access | Times Cited: 1

Assessment of KaraShieldTM properties in supporting the immune health of healthy subjects: a randomized, parallel, double-blind, placebo-controlled clinical study
Frank Lichtenberger, Krishna Rajendran, Keri Layton, et al.
International Journal of Basic & Clinical Pharmacology (2023) Vol. 13, Iss. 1, pp. 1-12
Open Access | Times Cited: 1

Intranasal and Inhaled Vaccines
Michael Y.T. Chow, Jenny K.W. Lam
AAPS introductions in the pharmaceutical sciences (2023), pp. 123-148
Closed Access | Times Cited: 1

Page 1

Scroll to top